Chrissa Schremp
Chrissa Schremp is Director of Business Development at Ardena. She supports biotech and pharmaceutical companies across the full development pathway, from preclinical strategy to clinical and commercial readiness.
Her experience spans drug development, analytical services, and CDMO partnerships. At Ardena, Chrissa works closely with clients to connect them with the company’s integrated service offering, including drug substance development and manufacturing, drug product formulation and manufacturing, nanomedicine solutions, bioanalysis, and CMC regulatory support. She is known for her collaborative approach and industry insight, helping support program continuity across complex therapeutic development programs.
Chrissa is based in the United States and brings broad experience supporting pharmaceutical innovators through integrated development and manufacturing strategies.
Amber Basinger
Amber Basinger is Director of Business Development at Ardena, focused on building strategic partnerships and supporting biotech and pharmaceutical companies across the Southern United States through Ardena’s integrated CDMO services. She brings more than 11 years of experience in business development within the life sciences industry.
Throughout her career, Amber has built strong relationships with emerging and established pharmaceutical organizations by supporting complex drug development and manufacturing programs. At Ardena, she works closely with clients to align development and manufacturing strategies with evolving program needs, supporting projects from early development through commercialization.
Prior to joining Ardena, Amber served as an Account Executive on Catalent’s Early Phase Small Molecule team, supporting clients across early-stage drug development initiatives.
